Spesolimab, Placebo matching to Spesolimab
1368-0130
Phase 3 small_molecule active
Quick answer
Spesolimab, Placebo matching to Spesolimab for Hidradenitis Suppurativa (HS) is a Phase 3 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Hidradenitis Suppurativa (HS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active